A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer.
Cao S, Zhang Y, Zhou Y, Rong W, Wang Y, Ling X, Zhang L, Li J, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Dermime S, Zhong R, Zhong H.
Cao S, et al. Among authors: ling x.
Transl Lung Cancer Res. 2022 Apr;11(4):607-616. doi: 10.21037/tlcr-22-171.
Transl Lung Cancer Res. 2022.
PMID: 35529793
Free PMC article.